Latest Alkaloids Stories
SAN DIEGO, Jan. 28, 2015 /PRNewswire/ -- Sorrento Therapeutics, Inc.
SAN DIEGO, Jan. 15, 2015 /PRNewswire/ -- Taxus Cardium Pharmaceuticals Group Inc. (Trading Symbol: CRXM) today announced the election of the following three new directors: Mr.
SAN DIEGO, Jan. 12, 2015 /PRNewswire/ -- Sorrento Therapeutics, Inc.
ReportsnReports.com announces addition of new report "2015 Deep Research Report on Global Paclitaxel Industry" to its research database. DALLAS, Jan.
Provides European Drug Development Strategy Update SARASOTA, Fla., Dec.
- Patent Covers Taxane Prodrug Nanoparticle Delivery Technology - EWING, N.J., Dec. 18, 2014 /PRNewswire/ -- Celator Pharmaceuticals, Inc.
CYRAMZA is the first treatment approved in the U.S. for use in combination with docetaxel in second-line metastatic non-small cell lung cancer INDIANAPOLIS, Dec.
The FDA has approved the drug Cyramza, to be used in combination with docetexal for the treatment of non-small-cell lung cancer (NSCLC).
SAN DIEGO, Dec. 3, 2014 /PRNewswire/ -- Sorrento Therapeutics, Inc.
- A serpent whose bite was fabled to produce intense thirst.